{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:24:37Z","timestamp":1740176677979,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-023-04040-7","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T12:02:05Z","timestamp":1695124925000},"page":"3696-3702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of different LI-RADS v2018 categories in high-risk patients undergoing CT- or MRI-based screening for hepatocellular carcinoma"],"prefix":"10.1007","volume":"48","author":[{"given":"Haneyeh","family":"Shahbazian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia J.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedighe Hosseini","family":"Shabanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devaraju","family":"Kanmaniraja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Reinus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihab","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude B.","family":"Sirlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5715-1403","authenticated-orcid":false,"given":"Victoria","family":"Chernyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"issue":"9","key":"4040_CR1","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.jacr.2017.02.050","volume":"14","author":"M Flusberg","year":"2017","unstructured":"Flusberg M, Ganeles J, Ekinci T, Goldberg-Stein S, Paroder V, Kobi M, et al. Impact of a Structured Report Template on the Quality of CT and MRI Reports for Hepatocellular Carcinoma Diagnosis. Journal of the American College of Radiology : JACR. 2017;14(9):1206-11.","journal-title":"Journal of the American College of Radiology : JACR."},{"issue":"3","key":"4040_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49.","journal-title":"CA Cancer J Clin."},{"issue":"2","key":"4040_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723-50.","journal-title":"Hepatology."},{"issue":"5","key":"4040_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1136\/gutjnl-2017-314981","volume":"67","author":"C Mueller","year":"2018","unstructured":"Mueller C, Waldburger N, Stampfl U, Kauczor HU, Schirmacher P, Sommer CM, et al. Non-invasive diagnosis of hepatocellular carcinoma revisited. Gut. 2018;67(5):991-3.","journal-title":"Gut."},{"issue":"3","key":"4040_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1148\/radiol.2018181494","volume":"289","author":"V Chernyak","year":"2018","unstructured":"Chernyak V, Fowler KJ, Kamaya A, Kielar AZ, Elsayes KM, Bashir MR, et al. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radiology. 2018;289(3):816-30.","journal-title":"Radiology."},{"key":"4040_CR6","doi-asserted-by":"crossref","unstructured":"Lee S, Kim YY, Shin J, Son WJ, Roh YH, Choi JY, et al. Percentages of Hepatocellular Carcinoma in LI-RADS Categories with CT and MRI: A Systematic Review and Meta-Analysis. Radiology. 2023:220646.","DOI":"10.1148\/radiol.220646"},{"issue":"1","key":"4040_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/gutjnl-2018-318193","volume":"69","author":"EN De Toni","year":"2020","unstructured":"De Toni EN, Schlesinger-Raab A, Fuchs M, Schepp W, Ehmer U, Geisler F, et al. Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study. Gut. 2020;69(1):168-76.","journal-title":"Gut."},{"issue":"6","key":"4040_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/MCG.0000000000000916","volume":"52","author":"Y Huang","year":"2018","unstructured":"Huang Y, Wallace MC, Adams LA, MacQuillan G, Garas G, Ferguson J, et al. Rate of Nonsurveillance and Advanced Hepatocellular Carcinoma at Diagnosis in Chronic Liver Disease. J Clin Gastroenterol. 2018;52(6):551-6.","journal-title":"J Clin Gastroenterol."},{"issue":"1","key":"4040_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/apt.13841","volume":"45","author":"O Simmons","year":"2017","unstructured":"Simmons O, Fetzer DT, Yokoo T, Marrero JA, Yopp A, Kono Y, et al. Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis. Alimentary pharmacology & therapeutics. 2017;45(1):169-77.","journal-title":"Alimentary pharmacology & therapeutics."},{"issue":"6","key":"4040_CR10","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","volume":"154","author":"K Tzartzeva","year":"2018","unstructured":"Tzartzeva K, Obi J, Rich NE, Parikh ND, Marrero JA, Yopp A, et al. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis. Gastroenterology. 2018;154(6):1706-18.e1.","journal-title":"Gastroenterology."},{"issue":"2","key":"4040_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cgh.2010.09.017","volume":"9","author":"NC Yu","year":"2011","unstructured":"Yu NC, Chaudhari V, Raman SS, Lassman C, Tong MJ, Busuttil RW, et al. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2011;9(2):161-7.","journal-title":"Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association."},{"issue":"1","key":"4040_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1148\/radiol.2017162080","volume":"285","author":"BR Kim","year":"2017","unstructured":"Kim BR, Lee JM, Lee DH, Yoon JH, Hur BY, Suh KS, et al. Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma. Radiology. 2017;285(1):134-46.","journal-title":"Radiology."},{"issue":"3","key":"4040_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/apt.12370","volume":"38","author":"C Pocha","year":"2013","unstructured":"Pocha C, Dieperink E, McMaken KA, Knott A, Thuras P, Ho SB. Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography -- a randomised study. Aliment Pharmacol Ther. 2013;38(3):303-12.","journal-title":"Aliment Pharmacol Ther."},{"issue":"4","key":"4040_CR14","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/jamaoncol.2016.3147","volume":"3","author":"SY Kim","year":"2017","unstructured":"Kim SY, An J, Lim YS, Han S, Lee JY, Byun JH, et al. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma. JAMA Oncol. 2017;3(4):456-63.","journal-title":"JAMA Oncol."},{"issue":"1","key":"4040_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00261-022-03702-2","volume":"48","author":"MJ King","year":"2023","unstructured":"King MJ, Lee KM, Rosberger S, Huang HH, Meza GH, Lewis S, et al. HCC screening with ultrasound: assessment of quality using ultrasound LI-RADS score. Abdom Radiol (NY). 2023;48(1):263-70.","journal-title":"Abdom Radiol (NY)."},{"issue":"3","key":"4040_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2214\/AJR.22.27405","volume":"219","author":"T Tiyarattanachai","year":"2022","unstructured":"Tiyarattanachai T, Fetzer DT, Kamaya A. Multicenter Study of ACR Ultrasound LI-RADS Visualization Scores on Serial Examinations: Implications for Surveillance Strategies. AJR American journal of roentgenology. 2022;219(3):445-52.","journal-title":"AJR American journal of roentgenology."},{"issue":"1","key":"4040_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00261-017-1325-y","volume":"43","author":"AR Kambadakone","year":"2018","unstructured":"Kambadakone AR, Fung A, Gupta RT, Hope TA, Fowler KJ, Lyshchik A, et al. LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. Abdom Radiol (NY). 2018;43(1):56-74.","journal-title":"Abdom Radiol (NY)."},{"issue":"8","key":"4040_CR18","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s00261-017-1105-8","volume":"42","author":"V Chernyak","year":"2017","unstructured":"Chernyak V, Kobi M, Flusberg M, Fruitman KC, Sirlin CB. Effect of threshold growth as a major feature on LI-RADS categorization. Abdom Radiol (NY). 2017;42(8):2089-100.","journal-title":"Abdom Radiol (NY)."},{"key":"4040_CR19","doi-asserted-by":"crossref","unstructured":"Fowler KJ, Bashir MR, Fetzer DT, Kitao A, Lee JM, Jiang H, et al. Universal Liver Imaging Lexicon: Imaging Atlas for Research and Clinical Practice. Radiographics : a review publication of the Radiological Society of North America, Inc.;43(2):e239001.","DOI":"10.1148\/rg.220066"},{"issue":"12","key":"4040_CR20","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.cgh.2008.08.005","volume":"6","author":"KL Andersson","year":"2008","unstructured":"Andersson KL, Salomon JA, Goldie SJ, Chung RT. Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2008;6(12):1418-24.","journal-title":"Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association."},{"issue":"3","key":"4040_CR21","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/hep.27304","volume":"61","author":"DG Mitchell","year":"2015","unstructured":"Mitchell DG, Bruix J, Sherman M, Sirlin CB. LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology. 2015;61(3):1056-65.","journal-title":"Hepatology."},{"issue":"6","key":"4040_CR22","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.2214\/AJR.21.26735","volume":"218","author":"DT Fetzer","year":"2022","unstructured":"Fetzer DT, Browning T, Xi Y, Yokoo T, Singal AG. Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations. AJR American journal of roentgenology. 2022;218(6):1010-20.","journal-title":"AJR American journal of roentgenology."},{"issue":"12","key":"4040_CR23","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.jacr.2019.05.020","volume":"16","author":"JD Millet","year":"2019","unstructured":"Millet JD, Kamaya A, Choi HH, Dahiya N, Murphy PM, Naveed MZ, et al. ACR Ultrasound Liver Reporting and Data System: Multicenter Assessment of Clinical Performance at One Year. Journal of the American College of Radiology : JACR. 2019;16(12):1656-62.","journal-title":"Journal of the American College of Radiology : JACR."},{"issue":"3","key":"4040_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.2214\/AJR.20.23447","volume":"217","author":"TJ Sevco","year":"2021","unstructured":"Sevco TJ, Masch WR, Maturen KE, Mendiratta-Lala M, Wasnik AP, Millet JD. Ultrasound (US) LI-RADS: Outcomes of Category US-3 Observations. AJR American journal of roentgenology. 2021;217(3):644-50.","journal-title":"AJR American journal of roentgenology."},{"issue":"1","key":"4040_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00261-015-0592-8","volume":"41","author":"RF Hanna","year":"2016","unstructured":"Hanna RF, Miloushev VZ, Tang A, Finklestone LA, Brejt SZ, Sandhu RS, et al. Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma. Abdom Radiol (NY). 2016;41(1):71-90.","journal-title":"Abdom Radiol (NY)."},{"issue":"2","key":"4040_CR26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1148\/radiol.2021211244","volume":"302","author":"CB van der Pol","year":"2022","unstructured":"van der Pol CB, McInnes MDF, Salameh JP, Levis B, Chernyak V, Sirlin CB, et al. CT\/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis. Radiology. 2022;302(2):326-35.","journal-title":"Radiology."}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-04040-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-023-04040-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-04040-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T03:08:46Z","timestamp":1701140926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-023-04040-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4040"],"URL":"https:\/\/doi.org\/10.1007\/s00261-023-04040-7","relation":{},"ISSN":["2366-0058"],"issn-type":[{"type":"electronic","value":"2366-0058"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"V. Chernyak: Consultant, Bayer. CB Sirlin: Dr. Sirlin reports research grants from ACR, Bayer, Foundation of NIH, GE, Gilead, Pfizer, Philips, Siemens; lab service agreements with Enanta, Gilead, ICON, Intercept, Nusirt, Shire, Synageva, Takeda; institutional consulting for BMS, Exact Sciences, IBM-Watson, Pfizer; Personal consulting for Altimmune, Ascelia Pharma, Blade, Boehringer, Epigenomics; and Guerbet; receipt of royalties and\/or honoraria from Medscape and Wolters Kluwer; ownership of stock options in Livivos; unpaid advisory board position in Quantix Bio. Dr. Sirlin serves as Chief Medical Officer for Livivos (unsalaried position with stock options), an appointment approved by his university.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional Review Board approval was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}